Structure and Pathology of Tau Protein in Alzheimer Disease

Abstract EN

Alzheimer's disease (AD) is the most common type of dementia.

In connection with the global trend of prolonging human life and the increasing number of elderly in the population, the AD becomes one of the most serious health and socioeconomic problems of the present.

Tau protein promotes assembly and stabilizes microtubules, which contributes to the proper function of neuron.

Alterations in the amount or the structure of tau protein can affect its role as a stabilizer of microtubules as well as some of the processes in which it is implicated.

The molecular mechanisms governing tau aggregation are mainly represented by several posttranslational modifications that alter its structure and conformational state.

Hence, abnormal phosphorylation and truncation of tau protein have gained attention as key mechanisms that become tau protein in a pathological entity.

Evidences about the clinicopathological significance of phosphorylated and truncated tau have been documented during the progression of AD as well as their capacity to exert cytotoxicity when expressed in cell and animal models.

This paper describes the normal structure and function of tau protein and its major alterations during its pathological aggregation in AD.